Cancer Health Treatment Update Helping Working Cancer Caregivers Manage Stress It’s difficult enough when a loved one is diagnosed with cancer, but spouses also face an array of practical problems. FDA Approves Lenvima Plus Keytruda for Advanced Kidney Cancer Targeted therapy and immunotherapy combination doubles response rate for people with advanced renal cell carcinoma. Pain Management Getting Worse for Patients With Terminal Cancer A new study has found a sharp decline in opioid access among terminal cancer patients in recent years. Special Enrollment Period for Obamacare Ends August 15 In January, Joe Biden opened this enrollment period for the Affordable Care Act. Plus: Those with a health plan can change their coverage. Advertisement New Concerns About Coronavirus Evolution in Immunosuppressed Patients Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Summer 2021 Check out our latest print edition! Newsfeed UPDATE: Special Enrollment Period for Obamacare Ends August 15 The Wagon Project: Family Hits the Road to Support Pediatric Cancer Patients Helping Working Cancer Caregivers Manage Stress Pain Management Getting Worse for Patients With Terminal Cancer Blog: Food and Drug Administration (FDA) FDA Approves Lenvima Plus Keytruda for Advanced Kidney Cancer FDA Grants First Full Approval for Treatment of Lymphoma in Dogs FDA Approves Rylaze for Leukemia and Lymphoma FDA Encourages Inclusion of People With Incurable Cancers in Clinical Trials Newsfeed UPDATE: Special Enrollment Period for Obamacare Ends August 15 The Wagon Project: Family Hits the Road to Support Pediatric Cancer Patients Helping Working Cancer Caregivers Manage Stress Pain Management Getting Worse for Patients With Terminal Cancer Blog: Food and Drug Administration (FDA) FDA Approves Lenvima Plus Keytruda for Advanced Kidney Cancer FDA Grants First Full Approval for Treatment of Lymphoma in Dogs FDA Approves Rylaze for Leukemia and Lymphoma FDA Encourages Inclusion of People With Incurable Cancers in Clinical Trials

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: